These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23626669)

  • 21. Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up.
    Chansavang A; Philippe A; Bozinovic I; Ben Hadj Ali K; Smadja D; Helley D; Darnige L; Mauge L
    Ann Hematol; 2022 Nov; 101(11):2453-2460. PubMed ID: 36125542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.
    Batsuli G; Deng W; Healey JF; Parker ET; Baldwin WH; Cox C; Nguyen B; Kahle J; Königs C; Li R; Lollar P; Meeks SL
    Blood; 2016 Oct; 128(16):2055-2067. PubMed ID: 27381905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF-binding site distant from its epitope.
    Dimitrov JD; Roumenina LT; Plantier JL; Andre S; Saboulard D; Meslier Y; Planchais C; Jacquemin M; Saint-Remy JM; Atanasov BP; Kaveri SV; Lacroix-Desmazes S
    J Thromb Haemost; 2010 Jul; 8(7):1524-31. PubMed ID: 20374449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8.
    Villard S; Piquer D; Raut S; Léonetti JP; Saint-Remy JM; Granier C
    J Biol Chem; 2002 Jul; 277(30):27232-9. PubMed ID: 12011059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.
    Batsuli G; Ito J; Mercer R; Baldwin WH; Cox C; Parker ET; Healey JF; Lollar P; Meeks SL
    J Thromb Haemost; 2018 Sep; 16(9):1779-1788. PubMed ID: 29981270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction.
    Gilles JG; Arnout J; Vermylen J; Saint-Remy JM
    Blood; 1993 Oct; 82(8):2452-61. PubMed ID: 7691260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
    Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; ;
    J Thromb Haemost; 2015 Jan; 13(1):47-53. PubMed ID: 25354263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of Factor VIII A2 Domain Residues 400-409 to a Factor X-Interactive Site in the Factor Xase Complex.
    Takeyama M; Nogami K; Sasai K; Furukawa S; Shima M
    Thromb Haemost; 2018 May; 118(5):830-841. PubMed ID: 29614522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of F.VIII:C antibodies by an enzyme-linked immunosorbent assay.
    Mondorf W; Ehrenforth S; Vigh Z; Last J; Tippmann G; Kreuz W; Scharrer I
    Vox Sang; 1994; 66(1):8-13. PubMed ID: 8146988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel factor VIII inhibitor epitopes using synthetic peptide arrays.
    Palmer DS; Dudani AK; Drouin J; Ganz PR
    Vox Sang; 1997; 72(3):148-61. PubMed ID: 9145485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.
    Batlle J; Gómez E; Rendal E; Torea J; Lourés E; Couselo M; Vila P; Sedano C; Tusell X; Magallón M; Quintana M; González-Boullosa R; López-Fernández MF
    Ann Hematol; 1996 May; 72(5):321-6. PubMed ID: 8645745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
    Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
    Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies.
    Nogami K; Soeda T; Matsumoto T; Kawabe Y; Kitazawa T; Shima M
    J Thromb Haemost; 2018 Jul; 16(7):1383-1390. PubMed ID: 29734520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
    Ware J; MacDonald MJ; Lo M; de Graaf S; Fulcher CA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):703-16. PubMed ID: 1283342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characterization of factor VIII antibody epitopes from haemophilia A patients using cellulose bound FVIII peptide libraries].
    Albert T; Lange S; Oldenburg J; Graw J; Schramm W; Hanfland P; Brackmann HH; Schwaab R
    Hamostaseologie; 2003 Feb; 23(1):13-7. PubMed ID: 12567194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell and T-cell epitopes in anti-factor VIII immune responses.
    Pratt KP; Thompson AR
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative measurement of FVIII inhibitors in hemophilia A patients using ELISA and the Bethesda assay.
    Kim SY; Kang SY; Lee WI
    Korean J Lab Med; 2010 Jun; 30(3):260-3. PubMed ID: 20603586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes.
    van Den Brink EN; Turenhout EA; Davies J; Bovenschen N; Fijnvandraat K; Ouwehand WH; Peters M; Voorberg J
    Blood; 2000 Jan; 95(2):558-63. PubMed ID: 10627462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients.
    Blanco AN; Peirano AA; Grosso SH; Gennari LC; Bianco RP; Lazzari MA
    Haematologica; 2000 Oct; 85(10):1045-50. PubMed ID: 11025595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
    Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
    J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.